ArticleJAMA2020
Research and Development Costs of New Drugs-Reply.
Article in JAMA, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- HopWD-DTA: a novel framework for drug-target affinity prediction fusing multi-hop neighborhoods and deep features.Journal of molecular modeling · 2026Article
- LKE-DTA: predicting drug-target binding affinity with large language model representations and knowledge graph embeddings.Molecular diversity · 2026Article
- Navigating the Biosimilars from Bench to Bedside in Juvenile Idiopathic Arthritis.Paediatric drugs · 2025Review
- MultiKD-DTA: Enhancing Drug-Target Affinity Prediction Through Multiscale Feature Extraction.Interdisciplinary sciences, computational life sciences · 2025Article
- A membrane permeability database for nonpeptidic macrocycles.Scientific data · 2025Article
- Integrating artificial intelligence into the modernization of traditional Chinese medicine industry: a review.Frontiers in pharmacology · 2024Review
- Integrated Molecular Modeling and Machine Learning for Drug Design.Journal of chemical theory and computation · 2023Review
- Perceiver CPI: a nested cross-attention network for compound-protein interaction prediction.Bioinformatics (Oxford, England) · 2023Article
- Article
- Antileishmanial Chemotherapy through Clemastine Fumarate Mediated Inhibition of theACS infectious diseases · 2021Article
Corrections and comments
- Comment on
- Comment on
- Comment on
- Erratum issued
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
32749488What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.